Evidence map›Paper›PMID 33173121›Full record

ArticleScientific reports2020

Author Correction: Integrin CD11b attenuates colitis by strengthening Src-Akt pathway to polarize anti-inflammatory IL-10 expression.

Xiang Hu, Chaofeng Han, Jing Jin, Kewei Qin, Hua Zhang, Tianliang Li, Nan Li, Xuetao Cao

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiang HuNational Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Chaofeng HanNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai, China. hcf@immunol.org.
Jing JinNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai, China.
Kewei QinNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai, China.
Hua ZhangNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai, China.
Tianliang LiNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai, China.
Nan LiNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai, China.
Xuetao CaoNational Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China. caoxt@immunol.org.
Second Military Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID33173121
PMCPMC7655800
OpenAlexW3098639104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.